Generic:
Lasmiditan
Therapeutic Class:
Anti-Migraine
Composition:
Each Lasmed tablet contains Lasmiditan 100 mg.
Description:
Lasmed (Lasmiditan) is an oral, first-in-class selective serotonin receptor agonist belonging to the ditan class that is used for the acute treatment of migraine headaches with or without aura in adults.
Indications:
Lasmed is indicated for the acute treatment of migraine with or without aura in adults.
Dosage:
The recommended initial dose in adults is 100 mg Lasmed for acute treatment of migraine attacks. If necessary, the dose can be increased to 200 mg for greater efficacy or can be decreased to 50 mg for greater tolerability.
If the migraine headache recurs within 24 hours of an initial response after taking 100 mg Lasmed, a second dose of the same strength may be taken. The second dose should not be taken within 2 hours of the initial dose. No more than 200 mg should be taken in 24 hours.
Presentations:
Lasmed 100 mg tablets are available in packs of 8 tablets.
